| 7.98 Data as of May 17 |  -0.02 / -0.25%Today’s Change | 5.44 Today|||52-Week Range 13.50 | -11.53% Year-to-Date |
| ARNA Sheds Light on Belviq Launch - Analyst Blog May 09 / Zacks.com | Arena Pharma Narrows Loss - Analyst Blog May 06 / Zacks.com |
| VIVUS Reports Wider Loss - Analyst Blog May 09 / Zacks.com |
| Previous close | 8.00 |
| Today’s open | 8.05 |
| Day’s range | -- - -- |
| Volume | 2,395,561 |
| Average volume (3 months) | 5,357,773 |
| Market cap | $1.7B |
| Dividend yield | -- |
| Earnings growth (last year) | +43.75% |
| Earnings growth (this year) | +68.89% |
| Earnings growth (next 5 years) | 0.00% |
| Revenue growth (last year) | +116.90% |
| P/E ratio | NM |
| Price/Sales | 64.26 |
| Price/Book | 17.59 |
| Today’s change | Today’s % change | |
|---|---|---|
| VPHMViroPharma Inc | +0.26 | +1.01% |
| IRWDIronwood Pharmaceuti... | -0.21 | -1.44% |
| MNKDMannkind Corp | +0.03 | +0.58% |
| MDCOThe Medicines Co | 0.00 | 0.00% |
| Next reporting date | July 23, 2013 |
| EPS forecast (this quarter) | $0.18 |
| Annual revenue (last year) | $27.6M |
| Annual profit (last year) | -$85.5M |
| Net profit margin | -309.85% |
Sector Health Technology |
Industry Biotechnology |
Chairman, President & Chief Executive Officer Jack Lief |
SVP-Operations & Head-Global Regulatory Affairs Craig M. Audet |
Corporate headquarters San Diego, California |
.
